Global Viral Vaccine Market Opportunities, Challenges, Strategies & Forecasts
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report studies the Viral Vaccine market, covering market size for segment by type (Attenuated Vaccine, Inactivated Vaccine, etc.), by application (Adults, Children, etc.), by sales channel (Direct Channel, Distribution Channel), by player (GSK, Merck, Novartis, Pfizer, Sanofi Pasteur, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Viral Vaccine from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Viral Vaccine market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Viral Vaccine including:
GSK
Merck
Novartis
Pfizer
Sanofi Pasteur
Bayer
Zoetis
AstraZeneca
Johnson & Johnson
CSL Limited
Astellas Pharma
Emergent BioSolutions
MedImmune
Serum Institute of India
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health
CNBG
Changsheng Life
Baxter
ChengDa Bio
Boehringer Ingelheim
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
Rong An
NuoCheng Bio
Hualan Bio
Tiantan Biological
Market split by Type, can be divided into:
Attenuated Vaccine
Inactivated Vaccine
Market split by Application, can be divided into:
Adults
Children
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Key Questions Answered in Report
Which is the most lucrative market
Which factors will impact the growth of the market
How will changing trends impact the strategies of market players
How can market players capture the low-hanging opportunities across regions
Which companies are leading the industry
What are the winning strategies of stakeholders in the market
Chapter 1 Viral Vaccine Market Overview
1.1 Viral Vaccine Definition
1.2 Global Viral Vaccine Market Size Status and Outlook (2016-2030)
1.3 Global Viral Vaccine Market Size Comparison by Region (2016-2030)
1.4 Global Viral Vaccine Market Size Comparison by Type (2016-2030)
1.5 Global Viral Vaccine Market Size Comparison by Application (2016-2030)
1.6 Global Viral Vaccine Market Size Comparison by Sales Channel (2016-2030)
1.7 Viral Vaccine Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Viral Vaccine Market Segment Analysis by Player
2.1 Global Viral Vaccine Sales and Market Share by Player (2019-2021)
2.2 Global Viral Vaccine Revenue and Market Share by Player (2019-2021)
2.3 Global Viral Vaccine Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Viral Vaccine Market Segment Analysis by Type
3.1 Global Viral Vaccine Market by Type
3.1.1 Attenuated Vaccine
3.1.2 Inactivated Vaccine
3.2 Global Viral Vaccine Sales and Market Share by Type (2016-2021)
3.3 Global Viral Vaccine Revenue and Market Share by Type (2016-2021)
3.4 Global Viral Vaccine Average Price by Type (2016-2021)
3.5 Leading Players of Viral Vaccine by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Viral Vaccine Market Segment Analysis by Application
4.1 Global Viral Vaccine Market by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Viral Vaccine Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Viral Vaccine by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Viral Vaccine Market Segment Analysis by Sales Channel
5.1 Global Viral Vaccine Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Viral Vaccine Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Viral Vaccine by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Viral Vaccine Market Segment Analysis by Region
6.1 Global Viral Vaccine Market Size and CAGR by Region (2016-2030)
6.2 Global Viral Vaccine Sales and Market Share by Region (2016-2021)
6.3 Global Viral Vaccine Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Viral Vaccine Market Share by Type
6.4.3 North America Viral Vaccine Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Viral Vaccine Market Share by Type
6.5.3 Europe Viral Vaccine Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Viral Vaccine Market Share by Type
6.6.3 Asia-Pacific Viral Vaccine Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Viral Vaccine Market Share by Type
6.7.3 South America Viral Vaccine Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Viral Vaccine Market Share by Type
6.8.3 Middle East & Africa Viral Vaccine Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Viral Vaccine Players
7.1 GSK
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Merck
7.3 Novartis
7.4 Pfizer
7.5 Sanofi Pasteur
7.6 Bayer
7.7 Zoetis
7.8 AstraZeneca
7.9 Johnson & Johnson
7.10 CSL Limited
7.11 Astellas Pharma
7.12 Emergent BioSolutions
7.13 MedImmune
7.14 Serum Institute of India
7.15 Encephalitis
7.16 Cochrane Collaboration
7.17 Sonic HealthPlus
7.18 Superdrug Health
7.19 CNBG
7.20 Changsheng Life
7.21 Baxter
7.22 ChengDa Bio
7.23 Boehringer Ingelheim
7.24 SINOVAC BIOTECH
7.25 Hissen
7.26 Walvax Biotechnology
7.27 Rong An
7.28 NuoCheng Bio
7.29 Hualan Bio
7.30 Tiantan Biological
Chapter 8 Upstream and Downstream Analysis of Viral Vaccine
8.1 Industrial Chain of Viral Vaccine
8.2 Upstream of Viral Vaccine
8.3 Downstream of Viral Vaccine
Chapter 9 Development Trend of Viral Vaccine (2022-2030)
9.1 Global Viral Vaccine Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Viral Vaccine Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Viral Vaccine Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Viral Vaccine Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Viral Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Viral Vaccine Example
Figure Global Viral Vaccine Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Viral Vaccine Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Viral Vaccine Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Viral Vaccine Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Viral Vaccine Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Viral Vaccine Sales by Player (2019-2021)
Table Global Viral Vaccine Sales Market Share by Player (2019-2021)
Figure Global Viral Vaccine Sales Market Share by Player in 2021
Table Global Viral Vaccine Revenue (Million $) by Player (2019-2021)
Table Global Viral Vaccine Revenue Market Share by Player (2019-2021)
Figure Global Viral Vaccine Revenue Market Share by Player in 2021
Table Global Viral Vaccine Average Price by Player (2019-2021)
Figure Global Viral Vaccine Average Price by Player in 2021
Figure Global Viral Vaccine Players Competition Situation – Top 5 Players’ Revenue Market Share in 2019
Figure Global Viral Vaccine Players Competition Trends – Top 5 Players’ Revenue Market Share in 2021
Figure Example of Attenuated Vaccine
Figure Global Attenuated Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Inactivated Vaccine
Figure Global Inactivated Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Global Viral Vaccine Sales by Type (2016-2021)
Table Global Viral Vaccine Sales Market Share by Type (2016-2021)
Figure Global Viral Vaccine Sales Market Share by Type in 2021
Table Global Viral Vaccine Revenue (Million $) by Type (2016-2021)
Table Global Viral Vaccine Revenue Market Share by Type (2016-2021)
Figure Global Viral Vaccine Revenue Market Share by Type in 2021
Table Global Viral Vaccine Average Price by Type (2016-2021)
Figure Global Viral Vaccine Average Price by Type in 2021
Table Leading Players of Viral Vaccine by Type in 2021
Figure Example of Adults
Figure Global Viral Vaccine for Adults Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Children
Figure Global Viral Vaccine for Children Revenue (Million $) and Growth Rate (2016-2021)
Table Global Viral Vaccine Sales by Application (2016-2021)
Table Global Viral Vaccine Sales Market Share by Application (2016-2021)
Figure Global Viral Vaccine Sales Market Share by Application in 2021
Table Leading Consumers of Viral Vaccine by Application in 2021
Figure Example of Direct Channel
Figure Global Viral Vaccine for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Viral Vaccine for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Viral Vaccine Revenue by Sales Channel (2016-2021)
Table Global Viral Vaccine Revenue Market Share by Sales Channel (2016-2021)
Figure Global Viral Vaccine Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Viral Vaccine by Sales Channel in 2021
Table Global Viral Vaccine Market Size and CAGR by Region (2016-2030)
Table Global Viral Vaccine Sales by Region (2016-2021)
Table Global Viral Vaccine Sales Market Share by Region (2016-2021)
Figure Global Viral Vaccine Sales Market Share by Region in 2021
Table Global Viral Vaccine Revenue (Million $) by Region (2016-2021)
Table Global Viral Vaccine Revenue Market Share by Region (2016-2021)
Figure Global Viral Vaccine Revenue Market Share by Region in 2021
Table North America Viral Vaccine Sales by Country (2016-2021)
Figure North America Viral Vaccine Sales Market Share by Country (2016-2021)
Table North America Viral Vaccine Revenue by Country (2016-2021)
Figure North America Viral Vaccine Revenue Market Share by Country (2016-2021)
Figure North America Viral Vaccine Market Share by Type in 2021
Figure North America Viral Vaccine Market Share by Application in 2021
Figure United States Viral Vaccine Sales and Growth Rate (2016-2021)
Figure United States Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Canada Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Mexico Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Viral Vaccine Sales by Country (2016-2021)
Figure Europe Viral Vaccine Sales Market Share by Country (2016-2021)
Table Europe Viral Vaccine Revenue by Country (2016-2021)
Figure Europe Viral Vaccine Revenue Market Share by Country (2016-2021)
Figure Europe Viral Vaccine Market Share by Type in 2021
Figure Europe Viral Vaccine Market Share by Application in 2021
Figure Germany Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Germany Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Viral Vaccine Sales and Growth Rate (2016-2021)
Figure UK Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure France Viral Vaccine Sales and Growth Rate (2016-2021)
Figure France Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Italy Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Russia Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Spain Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Viral Vaccine Sales by Country (2016-2021)
Figure Asia-Pacific Viral Vaccine Sales Market Share by Country (2016-2021)
Table Asia-Pacific Viral Vaccine Revenue by Country (2016-2021)
Figure Asia-Pacific Viral Vaccine Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Viral Vaccine Market Share by Type in 2021
Figure Asia-Pacific Viral Vaccine Market Share by Application in 2021
Figure China Viral Vaccine Sales and Growth Rate (2016-2021)
Figure China Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Japan Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Korea Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure India Viral Vaccine Sales and Growth Rate (2016-2021)
Figure India Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Southeast Asia Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Australia Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table South America Viral Vaccine Sales by Country (2016-2021)
Figure South America Viral Vaccine Sales Market Share by Country (2016-2021)
Table South America Viral Vaccine Revenue by Country (2016-2021)
Figure South America Viral Vaccine Revenue Market Share by Country (2016-2021)
Figure South America Viral Vaccine Market Share by Type in 2021
Figure South America Viral Vaccine Market Share by Application in 2021
Figure Brazil Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Brazil Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Argentina Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Colombia Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Viral Vaccine Sales by Country (2016-2021)
Figure Middle East & Africa Viral Vaccine Sales Market Share by Country (2016-2021)
Table Middle East & Africa Viral Vaccine Revenue by Country (2016-2021)
Figure Middle East & Africa Viral Vaccine Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Viral Vaccine Market Share by Type in 2021
Figure Middle East & Africa Viral Vaccine Market Share by Application in 2021
Figure UAE Viral Vaccine Sales and Growth Rate (2016-2021)
Figure UAE Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Viral Vaccine Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Viral Vaccine Sales and Growth Rate (2016-2021)
Figure South Africa Viral Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of GSK
Table Viral Vaccine Introduction of GSK
Table Viral Vaccine Sales, Price, Revenue, Gross Margin and Market Share of GSK (2019-2021)
Table Industrial Chain of Viral Vaccine
Table Manufacturing Cost Structure of Viral Vaccine
Table General Manufacturing Process of Viral Vaccine
Table Leading Distributors/Dealers of Viral Vaccine
Table Leading Consumers of Viral Vaccine
Figure Global Viral Vaccine Sales and Growth Rate Forecast (2022-2030)
Figure Global Viral Vaccine Revenue and Growth Rate Forecast (2022-2030)
Table Global Viral Vaccine Market Size and CAGR Forecast by Region (2022-2030)
Table Global Viral Vaccine Market Size and CAGR Forecast by Type (2022-2030)
Table Global Viral Vaccine Market Size and CAGR Forecast by Application (2022-2030)
Table Global Viral Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030)
Research Methodology:
Viral Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|